Venetoclax in Combination With ASTX727

Venetoclax in Combination With ASTX727, an All-ORal Therapy for Chronic Myelomonocytic Leukemia and Other MDS/MPN With Excess Blasts (VICTORY-MDS/MPN): A Randomized, Phase 2 Trial

Near Add Your Location

Center of Excellence

University of Kansas Cancer Center (Westwood)
Westwood, KS
  • Accepting patients
UVA Cancer Center
University of Virginia Health System
Charlottesville, VA
  • Accepting patients

Center of Excellence

Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
  • Accepting patients

Center of Excellence

USC Norris Comprehensive Cancer Center - Keck School of Medicine
University of Southern California
Los Angeles, CA
  • Accepting patients
UCI Health - Costa Mesa
Costa Mesa, CA
  • Accepting patients
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients

Center of Excellence

Wake Forest Baptist - Comprehensive Cancer Center
Atrium Health
Winston-Salem, NC
  • Accepting patients
UCI Health (Laguna Hills)
Laguna Hills, CA
  • Accepting patients
495 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.